Amy B. Heimberger MD (She/Her)
Brain & Spinal Tumor
Professor of Neurological Surgery, Northwestern Medicine Vice Chair of Research Scientific Director Malnati Brain Tumor Institute Int. Assoc. Director Translational Research Laurie Cancer Center
Join to View Full Profile
675 N Saint Clair StSte 20-100Chicago, IL 60611
Phone+1 312-695-8143
Fax+1 312-695-4430
Dr. Heimberger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Neurological Surgery, 1996 - 2002- Duke University HospitalInternship, Transitional Year, 1995 - 1996
Washington University in St. Louis School of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2024 - Present
IL State Medical License 2021 - 2026
TX State Medical License 2003 - 2022
OK State Medical License 2020 - 2021
NC State Medical License 1995 - 2002
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Elected Member The American Society for Clinical Investigation, 2011
- Fellow (FAANS) American Association of Neurological Surgeons
Clinical Trials
- STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain Start of enrollment: 2018 Jul 13
Publications & Presentations
PubMed
- The excitatory milieu in glioma: mechanisms and therapeutic avenues.Bobak F Khalili, Karan Dixit, David O Kamson, Craig Horbinski, Delilah J Przybyla
Neuro-Oncology. 2025-04-18 - Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade.Chia-Yang Hung, Elaine Y Kang, Karol Jacek, Chunsong Yu, Xiaowei Zhang
Neuro-Oncology. 2025-04-11 - IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.Jacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, Hinda Najem, Kanish Mirchia
Biorxiv. 2025-03-14
Journal Articles
- Profiles of Brain Metastases: Prioritization of Therapeutic TargetsRaymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
Press Mentions
Improving the Science and Treatment of GlioblastomaOctober 16th, 2024- Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of GlioblastomaSeptember 9th, 2024
- 5 Women in Neurosurgery to KnowAugust 12th, 2024
- Join now to see all
Grant Support
- A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and RadiationNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
- Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapseUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2026
- Modulation of Microglia and T Cell Interactions in Malignant GliomaNORTHWESTERN UNIVERSITY AT CHICAGO2007–2026
- Effects Of A Novel Phospho-Stat2 Inhibitor For Treatment Of Stage IV MelanomaNational Cancer Institute2010–2011
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
